Topics
Innovation
Laser
Medical
Practice
Research
Surgical
Training
New solutions for glaucoma care are in sight.
View Issue
In This Issue
Arsham Sheybani, MD
When is conjunctival transmission a concern, and how do asymptomatic carriers affect disease transmission?
S. Asha Balakrishnan, MD
Tools for expanding glaucoma diagnosis and management beyond the office.
Kateki Vinod, MD, and Sarwat Salim, MD, FACS
Despite initial delays in patient care, glaucoma treatment in Wuhan has returned to normal.
Tu Haixia, MD, and Wang Yong, MD
Which type of surgical intervention is most appropriate?
Devesh K. Varma, MD, FRCSC; Steven J. Gedde, MD; Joseph F. Panarelli, MD; and Oluwatosin Smith, MD
The importance of strain and chemical composition.
Ahmad A. Aref, MD, MBA
Virtual options can almost always be offered to patients with neuro-ophthalmologic conditions.
Kevin E. Lai, MD; Devin D. Mackay, MD; and Melissa W. Ko, MD
Reflections on the ups and downs of addressing glaucoma.
Amol Sura, MD, and Albert S. Khouri, MD
What factors influence a lasting evolution in care?
Jason Bacharach, MD
Surgeons describe their initial cases and the insights gained using a new pharmaceutical solution for glaucoma.
Gagan Sawhney, MD; Roman Krivochenitser, MD; Blake K. Williamson, MD, MPH; and Steven R. Sarkisian Jr, MD
How do new treatment options fit in with existing therapeutic strategies?
I. Paul Singh, MD
New therapeutics and drug delivery systems are in the works.
Subscribe
Stay up to date all on all things Glaucoma by signing up to receive our print publication or subscribe to our email alerts.
